August 18, 2025 Experience Financing for Advent’s $2.5 billion Sapiens take-private acquisition We are advising the financing sources on the acquisition financing
June 25, 2025 Experience StoneX Group $625 million senior secured notes offering We advised StoneX on the high-yield notes offering
June 5, 2025 Experience Sabre $1.325 billion notes offering and concurrent cash tender offer We advised Sabre on its high-yield notes offering and on a debt tender offer
May 20, 2025 Experience Shift4 Payments $550 million and €680 million notes offerings The high-yield notes are part of the financing for Shift4 Payments’ acquisition of Global Blue Group Holdings
May 7, 2025 Experience Shift4 Payments $1 billion mandatory convertible preferred stock offering The shares are listed on the New York Stock Exchange
April 30, 2025 Experience QXO $2.25 billion senior secured notes offering The debut high-yield notes are part of the financing for QXO’s acquisition of Beacon Roofing Supply
April 14, 2025 Experience StoneX Group $900 million acquisition of R.J. O'Brien & Associates We are advising StoneX on the transaction
March 11, 2025 Experience Bread Financial Holdings $400 million subordinated notes offering We advised Bread Financial on its subordinated debt offering
January 10, 2025 Experience Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase We are advising Royalty Pharma on the transaction
January 7, 2025 Experience Teoxane proposal to acquire Revance Therapeutics We are advising Teoxane on the proposed acquisition